Predictive genetic profiles for β-agonist therapy in asthma. A future under construction.

@article{Ortega2015PredictiveGP,
  title={Predictive genetic profiles for $\beta$-agonist therapy in asthma. A future under construction.},
  author={V. Ortega},
  journal={American journal of respiratory and critical care medicine},
  year={2015},
  volume={191 5},
  pages={
          494-6
        }
}
  • V. Ortega
  • Published 2015
  • Medicine
  • American journal of respiratory and critical care medicine
The goal of pharmacogenetic research is to determine the effects of genetic variation on the response of a phenotype to a pharmacologic agent. Pharmacogenetics has the potential to identify genetic biomarkers that can be used to stratify individuals for personalized therapies and, thus, place the individual at the center of therapeutic management decisions for precision medicine. Personalized medicine has a potential role in the treatment of asthma as a result of high interindividual… Expand
6 Citations

References

SHOWING 1-10 OF 16 REFERENCES
A genome-wide association study of bronchodilator response in Latinos implicates rare variants.
Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene
A genome-wide association study of bronchodilator response in asthmatics
Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
...
1
2
...